Viatris has made a play to expand its branded medicines business by licensing two late-stage drugs from Idorsia – for acute myocardial infarction (AMI) and systemic lupus erythematosus (SLE ...

changes in healthcare and pharmaceutical laws and regulations in the U.S. and abroad; any regulatory, legal or other impediments to Viatris' ability to bring new products to market, including but ...

This leaflet answers some common questions about RAMIPRIL VIATRIS. It does not contain all of the available information. It does not take the place of talking to your doctor or pharmacist.

This is not all the information that is available on LAMIVUDINE VIATRIS tablets. If you have any more questions or are not sure about anything, ask your doctor or pharmacist. Pharmaceutical ...